These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 1454086)

  • 1. Sympathetic overactivity in patients with chronic renal failure.
    Converse RL; Jacobsen TN; Toto RD; Jost CM; Cosentino F; Fouad-Tarazi F; Victor RG
    N Engl J Med; 1992 Dec; 327(27):1912-8. PubMed ID: 1454086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
    N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.
    Scherrer U; Vissing SF; Morgan BJ; Rollins JA; Tindall RS; Ring S; Hanson P; Mohanty PK; Victor RG
    N Engl J Med; 1990 Sep; 323(11):693-9. PubMed ID: 2388667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild chronic renal insufficiency induces sympathetic overactivity.
    Tinucci T; Abrahão SB; Santello JL; Mion D
    J Hum Hypertens; 2001 Jun; 15(6):401-6. PubMed ID: 11439315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of sympathetic nervous activity in renal injury and end-stage renal disease.
    Masuo K; Lambert GW; Esler MD; Rakugi H; Ogihara T; Schlaich MP
    Hypertens Res; 2010 Jun; 33(6):521-8. PubMed ID: 20339374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preeclampsia -- a state of sympathetic overactivity.
    Schobel HP; Fischer T; Heuszer K; Geiger H; Schmieder RE
    N Engl J Med; 1996 Nov; 335(20):1480-5. PubMed ID: 8890098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of the kallikrein-kinin, renin-angiotensin and sympathetic-adrenal systems in chronic kidney failure patients during hemodialysis treatment].
    Neĭmark MI
    Ter Arkh; 1984; 56(9):102-5. PubMed ID: 6569758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension in end-stage renal failure: role of sympathetic nervous system, sodium balance and renal pressor system.
    Zucchelli P; Zuccala A; Sturani A; Degli Esposti E; Ligabue A; Santoro A; Gattiani A; Chiarini C
    Life Support Syst; 1983; 1(2):101-11. PubMed ID: 6381895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic overactivity in uremia.
    Ksiazek A; Załuska W
    J Ren Nutr; 2008 Jan; 18(1):118-21. PubMed ID: 18089457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic regulation of blood pressure in chronic renal failure.
    Lilley JJ; Golden J; Stone RA
    J Clin Invest; 1976 May; 57(5):1190-200. PubMed ID: 1262465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic factors and hypertension in chronic renal failure.
    Campese VM
    J Nephrol; 1997; 10(4):184-7. PubMed ID: 9377724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The diagnosis and treatment of arterial hypertension in patients on hemodialysis treatment and after a kidney allograft].
    Mazo EB; Akopian AS; Iankovoĭ AG; Koriakin MV
    Urol Nefrol (Mosk); 1990; (3):23-30. PubMed ID: 2204167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.
    Neumann J; Ligtenberg G; Oey L; Koomans HA; Blankestijn PJ
    J Am Soc Nephrol; 2004 Nov; 15(11):2902-7. PubMed ID: 15504943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic nerve activity in end-stage renal disease.
    Hausberg M; Kosch M; Harmelink P; Barenbrock M; Hohage H; Kisters K; Dietl KH; Rahn KH
    Circulation; 2002 Oct; 106(15):1974-9. PubMed ID: 12370222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
    Ruzicka M; Coletta E; Leenen FH
    Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurogenic factors in hypertension: therapeutic implications.
    Campese VM
    Ann Ital Med Int; 1994 Oct; 9 Suppl():39S-43S. PubMed ID: 7857755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.